Sino-Biocan
Beijing
About Sino-Biocan
Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $29.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2024)
- Website: sino-biocan.com
- Phone: 1-108-518-8963
Industries & Categories
Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sino-biocan-141614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.